Selected research
Market Structure
Global ABO Blood Group Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global ABO Blood Group Reagent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for ABO Blood Group Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for ABO Blood Group Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for ABO Blood Group Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for ABO Blood Group Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of ABO Blood Group Reagent include SHPBC, Kinghawk, Dominion Biologicals Limited, CE-Immundiagnostika GmbH and Brother Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global ABO Blood Group Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of ABO Blood Group Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents ABO Blood Group Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the ABO Blood Group Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.
ABO Blood Group Reagent Segment by Company
SHPBC
Kinghawk
Dominion Biologicals Limited
CE-Immundiagnostika GmbH
Brother Biotech
ABO Blood Group Reagent Segment by Type
Positive Identification
Reverse Identification
ABO Blood Group Reagent Segment by Application
Blood Bank
Research
Hospital
Other
ABO Blood Group Reagent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ABO Blood Group Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ABO Blood Group Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ABO Blood Group Reagent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the ABO Blood Group Reagent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ABO Blood Group Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of ABO Blood Group Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of ABO Blood Group Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Positive Identification
- Reverse Identification
Applications
- Blood Bank
- Research
- Hospital
- Other
Companies covered
- SHPBC
- Kinghawk
- Dominion Biologicals Limited
- CE-Immundiagnostika GmbH
- Brother Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global ABO Blood Group Reagent Market Size, 2021 VS 2025 VS 2032
- 1.3 Global ABO Blood Group Reagent Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global ABO Blood Group Reagent Sales Estimates and Forecasts (2021-2032)
- 1.5 Global ABO Blood Group Reagent Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global ABO Blood Group Reagent Market Dynamics
- 2.1 ABO Blood Group Reagent Industry Trends
- 2.2 ABO Blood Group Reagent Industry Drivers
- 2.3 ABO Blood Group Reagent Industry Opportunities and Challenges
- 2.4 ABO Blood Group Reagent Industry Restraints
3 ABO Blood Group Reagent Market by Manufacturers
- 3.1 Global ABO Blood Group Reagent Revenue by Manufacturers (2021-2026)
- 3.2 Global ABO Blood Group Reagent Sales by Manufacturers (2021-2026)
- 3.3 Global ABO Blood Group Reagent Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global ABO Blood Group Reagent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global ABO Blood Group Reagent Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global ABO Blood Group Reagent Manufacturers, Product Type & Application
- 3.7 Global ABO Blood Group Reagent Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global ABO Blood Group Reagent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 ABO Blood Group Reagent Players Market Share by Revenue in 2025
- 3.8.3 2025 ABO Blood Group Reagent Tier 1, Tier 2, and Tier 3
4 ABO Blood Group Reagent Market by Type
- 4.1 ABO Blood Group Reagent Type Introduction
- 4.1.1 Positive Identification
- 4.1.2 Reverse Identification
- 4.2 Global ABO Blood Group Reagent Sales by Type
- 4.2.1 Global ABO Blood Group Reagent Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global ABO Blood Group Reagent Sales by Type (2021-2032)
- 4.2.3 Global ABO Blood Group Reagent Sales Market Share by Type (2021-2032)
- 4.3 Global ABO Blood Group Reagent Revenue by Type
- 4.3.1 Global ABO Blood Group Reagent Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global ABO Blood Group Reagent Revenue by Type (2021-2032)
- 4.3.3 Global ABO Blood Group Reagent Revenue Market Share by Type (2021-2032)
5 ABO Blood Group Reagent Market by Application
- 5.1 ABO Blood Group Reagent Application Introduction
- 5.1.1 Blood Bank
- 5.1.2 Research
- 5.1.3 Hospital
- 5.1.4 Other
- 5.2 Global ABO Blood Group Reagent Sales by Application
- 5.2.1 Global ABO Blood Group Reagent Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global ABO Blood Group Reagent Sales by Application (2021-2032)
- 5.2.3 Global ABO Blood Group Reagent Sales Market Share by Application (2021-2032)
- 5.3 Global ABO Blood Group Reagent Revenue by Application
- 5.3.1 Global ABO Blood Group Reagent Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global ABO Blood Group Reagent Revenue by Application (2021-2032)
- 5.3.3 Global ABO Blood Group Reagent Revenue Market Share by Application (2021-2032)
6 Global ABO Blood Group Reagent Sales by Region
- 6.1 Global ABO Blood Group Reagent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global ABO Blood Group Reagent Sales by Region (2021-2032)
- 6.2.1 Global ABO Blood Group Reagent Sales by Region (2021-2026)
- 6.2.2 Global ABO Blood Group Reagent Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America ABO Blood Group Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America ABO Blood Group Reagent Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe ABO Blood Group Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe ABO Blood Group Reagent Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific ABO Blood Group Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific ABO Blood Group Reagent Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa ABO Blood Group Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa ABO Blood Group Reagent Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global ABO Blood Group Reagent Revenue by Region
- 7.1 Global ABO Blood Group Reagent Revenue by Region
- 7.1.1 Global ABO Blood Group Reagent Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global ABO Blood Group Reagent Revenue by Region (2021-2026)
- 7.1.3 Global ABO Blood Group Reagent Revenue by Region (2027-2032)
- 7.1.4 Global ABO Blood Group Reagent Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America ABO Blood Group Reagent Revenue (2021-2032)
- 7.2.2 North America ABO Blood Group Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe ABO Blood Group Reagent Revenue (2021-2032)
- 7.3.2 Europe ABO Blood Group Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific ABO Blood Group Reagent Revenue (2021-2032)
- 7.4.2 Asia-Pacific ABO Blood Group Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa ABO Blood Group Reagent Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa ABO Blood Group Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 SHPBC
- 8.1.1 SHPBC Company Information
- 8.1.2 SHPBC Business Overview
- 8.1.3 SHPBC ABO Blood Group Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 SHPBC ABO Blood Group Reagent Product Portfolio
- 8.1.5 SHPBC Recent Developments
- 8.2 Kinghawk
- 8.2.1 Kinghawk Company Information
- 8.2.2 Kinghawk Business Overview
- 8.2.3 Kinghawk ABO Blood Group Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Kinghawk ABO Blood Group Reagent Product Portfolio
- 8.2.5 Kinghawk Recent Developments
- 8.3 Dominion Biologicals Limited
- 8.3.1 Dominion Biologicals Limited Company Information
- 8.3.2 Dominion Biologicals Limited Business Overview
- 8.3.3 Dominion Biologicals Limited ABO Blood Group Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Dominion Biologicals Limited ABO Blood Group Reagent Product Portfolio
- 8.3.5 Dominion Biologicals Limited Recent Developments
- 8.4 CE-Immundiagnostika GmbH
- 8.4.1 CE-Immundiagnostika GmbH Company Information
- 8.4.2 CE-Immundiagnostika GmbH Business Overview
- 8.4.3 CE-Immundiagnostika GmbH ABO Blood Group Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 CE-Immundiagnostika GmbH ABO Blood Group Reagent Product Portfolio
- 8.4.5 CE-Immundiagnostika GmbH Recent Developments
- 8.5 Brother Biotech
- 8.5.1 Brother Biotech Company Information
- 8.5.2 Brother Biotech Business Overview
- 8.5.3 Brother Biotech ABO Blood Group Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Brother Biotech ABO Blood Group Reagent Product Portfolio
- 8.5.5 Brother Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 ABO Blood Group Reagent Value Chain Analysis
- 9.1.1 ABO Blood Group Reagent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 ABO Blood Group Reagent Production Mode & Process
- 9.2 ABO Blood Group Reagent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 ABO Blood Group Reagent Distributors
- 9.2.3 ABO Blood Group Reagent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst